Venturelab
close

Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston

31.03.2022 10:00, Isabelle Mitchell

An expert jury selected the 10 Venture Leaders Medtech 2022: In June, the newest members of the Swiss National Startup team will travel to Boston and Cambridge to explore the US medtech startup ecosystem and connect with investors, industry leaders, and experts. The Venture Leaders Medtech program is organized by Venturelab and supported by EPF Lausanne, ETH Zurich, Hansjörg Wyss, Helbling Technik, Kellerhals Carrard, Paul Scherrer Institut, Swissnex Boston, Canton of Vaud, Canton of Zurich, and Venture Leader alumnus Dominik Lysek.

For the second consecutive year, the Venture Leaders Medtech will represent Swiss innovation in the United States. During the week-long roadshow, the 10 Venture Leaders will pitch to key US investors and meet with leaders and experts of the medtech industry. “With its focus on quality and precision, the Swiss medtech industry provides highly specialized expertise for a global market,” said Jordi Montserrat, managing partner at Venturelab. “The innovative power of the Venture Leaders Medtech 2022 is remarkable: The solutions have the potential to transform the industry, and I am excited to introduce the entrepreneurs to Boston’s investor scene.”  

To select the 10 Venture Leaders Medtech 2022, a jury of professional investors and medtech experts reviewed almost 60 applications. The 10 selected startups improve diagnostics, treatments, and well-being with innovative solutions covering artificial intelligence, sensors, smart devices, and robotics.

Boston is one of the world’s major life sciences hubs and the ideal springboard for ambitious startups on their way to global expansion. By building a strong network, the entrepreneurs will be able to accelerate their international growth. “Venture Leaders Medtech in Boston has boosted our contacts in the USA in an unprecedented way. Thanks to the program, we have been able to fine-tune our go-to-market strategy in the largest medtech market in the world,” said Francesco Cecchini Manara, founder and CEO of Gondola Medical Technologies, a Venture Leader Medtech 2021. 

Venturelab has been organizing international roadshows for the Swiss National Startup Teams for 17 years. The ambitious entrepreneurs and their promising startups are introduced to high-class investors and potential customers in leading technology hubs such as Silicon Valley, Boston, New York, London, Munich, Shanghai, Beijing, Shenzhen, and Barcelona.


Follow the entrepreneurs and the Venture Leaders Medtech roadshow from June 19 to June 23, 2022, on social media using the hashtag #VLeadersMedtech or on www.venture-leaders.ch/medtech




Learn more about the Venture Leaders Medtech 2022

aiEndoscopic AG: We combine AI with robotics to develop smart endoscopes

The current scarcity and forecasted shortage of skilled healthcare workers lead to more and more problems in experience-based tasks, such as endoscopy. aiE combines artificial intelligence with rob... Read more

Arbrea Labs AG: Growing the Medical Aesthetic Care with AI & Digital Humans

Arbrea is spearheading the aesthetic metaverse revolution with the first mobile Medical Aesthetic Marketspace powered by AI and Digital Humans. Our cutting-edge AI, AR, and 3D technologies are transfo... Read more

ArcoScreen SA: Improving drug discovery through patient cell screening.

ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology ... Read more

Bearmind SA: Wearable technology to prevent brain injuries in sports

Bearmind is an EPFL spin-off developing and commercializing in-built helmet sensors and software for brain injury prevention and performance monitoring in Sports. We are developing sensors and alg... Read more

EarlySight SA: Imaging early signs of retinal diseases years in advance

EarlySight is developing a medical device to help doctors detect and monitor eye diseases at early stage thanks to unprecedented imaging of the eye. Many eye diseases (e.g. AMD, glaucoma) are starti... Read more

MOMM Diagnostics AG: Rapid diagnostic tests for pregnancy complications

MOMM Diagnostics develops rapid, cost-effective diagnostic tests for pregnancy complications. préXclude® is our first test in development to diagnose and prognose preeclampsia a leading cause of death... Read more

Oncobit AG: Enabling personalised cancer care

Oncobit is a spinoff from the University Hospital of Zurich and has developed a scalable and data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers ... Read more

Rea Diagnostics SA: We develop technology to monitor high risk pregnancies

Rea developed the first at-home diagnostic test that tracks biochemical markers of preterm birth (PTB). Our solution allows doctors to continuously follow up pregnant women at risk of PTB to anticipat... Read more

TWIICE SA: Powered exoskeletons for walking assistance

Every year, 250000 people suffer a spinal cord injury leading to permanent paraplegia. TWIICE enables these individuals to live life to the fullest through wearable robotics. We help to overcome human... Read more